Preclinical and Translational PET/MR Imaging

Journal of Nuclear Medicine

Hans F. Wehrl¹  Stefan Wiehr¹  Sergios Gatidis¹  Johannes Schwenck¹  Wolfgang M. Thaiss¹  Florian C. Maier¹  Mathew R. Divine¹  Bernd J. Pichler¹  Anna-Maria Rolle¹  Grant T. Gullberg¹ 

关键词: PET/MRI;    oncology;    cardiology;    neurology;    connectomics;   

DOI  :  10.2967/jnumed.113.129221

学科分类：医学（综合）

来源: Society of Nuclear Medicine

【 摘 要 】

Combined PET and MR imaging (PET/MR imaging) has progressed tremendously in recent years. The focus of current research has shifted from technologic challenges to the application of this new multimodal imaging technology in the areas of oncology, cardiology, neurology, and infectious diseases. This article reviews studies in preclinical and clinical translation. The common theme of these initial results is the complementary nature of combined PET/MR imaging that often provides additional insights into biologic systems that were not clearly feasible with just one modality alone. However, in vivo findings require ex vivo validation. Combined PET/MR imaging also triggers a multitude of new developments in image analysis that are aimed at merging and using multimodal information that ranges from better tumor characterization to analysis of metabolic brain networks. The combination of connectomics information that maps brain networks derived from multiparametric MR data with metabolic information from PET can even lead to the formation of a new research field that we would call cometomics that would map functional and metabolic brain networks. These new methodologic developments also call for more multidisciplinarity in the field of molecular imaging, in which close interaction and training among clinicians and a variety of scientists is needed.

【 授权许可】

Unknown